Strides Arcolab stock up on US FDA nod

Shares in Strides Arcolab Ltd rose by 5% after company received US FDA approval for Gemcitabine injection.

Written by Agencies
Mumbai | July 26, 2011 11:08 AM IST

1 min read

Shares in Strides Arcolab Ltd rose more than 5 per cent after the company said it has received US FDA approval for generic version of Gemcitabine injection used in the treatment of cancer,dealers said. At about 10 am shares were up 3.81 per cent to 381.55 rupees in a flat Mumbai market.

Company INFO